Indian drug regulator examining WHO move on Covaxin; may seek update from company
In the light of the World Health Organisation (WHO)’s move to suspend supply of Covaxin produced by Hyderabad- headquartered Bharat Biotech, through UN procurement agencies, those in the Indian vaccine industry feel the focus will now increasingly be on the Indian drug regulator – the office of the Drugs Controller General of India (DCGI) and … Read more